Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M654Revenue $M277Net Margin (%)-3.0Altman Z-Score2.2
Enterprise Value $M826EPS $-0.1Operating Margin %-0.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-3.9Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-42.6ROA % (ttm)-1.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.1ROIC % (ttm)65.4Gross Margin Increase y-yN

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIJoel Greenblatt 2014-09-30 Sold Out -0.03%$18.7 - $22.89
($20.45)
$ 19.74-3%Sold Out0
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 19.7417%Reduce 47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 19.7417%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 19.7445%New holding48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 19.7461%New holding228,216
AMRIJohn Rogers 2013-03-31 Sold Out -0.04%$5.28 - $10.84
($7.56)
$ 19.74161%Sold Out0
AMRIJohn Rogers 2012-12-31 Reduce-0.01%$3.45 - $5.5
($4.25)
$ 19.74364%Reduce 27.34%372,844
AMRIJohn Rogers 2012-06-30 Buy 0.03%$2.32 - $3.22
($2.81)
$ 19.74602%New holding473,769
AMRIFirst Eagle Investment 2010-12-31 Sold Out $5.05 - $6.93
($5.92)
$ 19.74233%Sold Out0
AMRIFirst Eagle Investment 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 19.74179%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
D AMBRA THOMAS E PHDDirector 2015-05-11Sell20,000$19.113.3 view
D AMBRA CONSTANCE M10% Owner 2015-05-11Sell20,000$19.113.3 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-05-08Sell14,500$19.272.44 view
CABLE STUART M10% Owner 2015-05-01Sell30,000$17.8710.46 view
D AMBRA THOMAS E PHDDirector 2015-04-10Sell20,000$18.56.7 view
D AMBRA CONSTANCE M10% Owner 2015-04-10Sell20,000$18.56.7 view
CABLE STUART M10% Owner 2015-04-01Sell30,000$17.2114.7 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-03-17Sell3,500$18.536.53 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-03-17Sell3,500$18.536.53 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-03-13Sell441$18.795.06 view

Press Releases about AMRI :

    Quarterly/Annual Reports about AMRI:

      News about AMRI:

      Articles On GuruFocus.com
      Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 
      View on AMRI Jun 27 2010 
      AMRI Announces Second Quarter 2009 Results Aug 04 2009 
      AMRI Announces Fourth Quarter 2008 Results Feb 09 2009 
      AMRI Names Senior Director, Analytical and Quality Services Jan 12 2009 

      More From Other Websites
      AMRI to Present at Jefferies 2015 Healthcare Conference May 20 2015
      AMRI to Present at Jefferies 2015 Healthcare Conference May 20 2015
      ALBANY MOLECULAR RESEARCH INC Financials May 15 2015
      10-Q for Albany Molecular Research, Inc. May 10 2015
      ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report May 08 2015
      ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2015
      Albany Molecular Research posts 1Q loss May 05 2015
      Albany Molecular Research posts 1Q loss May 05 2015
      AMRI Announces First Quarter 2015 Results May 05 2015
      Q1 2015 Albany Molecular Research Inc Earnings Release - Before Market Open May 05 2015
      10-K for Albany Molecular Research, Inc. May 04 2015
      AMRI First Quarter Earnings May 04 2015
      AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May 01 2015
      AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May 01 2015
      5 Stocks Ready for Breakouts Apr 24 2015
      AMRI to Announce First Quarter 2015 Results Apr 21 2015
      ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Apr 07 2015
      AMRI to Close Holywell, U.K. API Manufacturing Facility Apr 02 2015
      ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual Report Mar 16 2015
      AMRI to Present at Barclays Global Healthcare Conference Feb 25 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK